Checkpoint Inhibitors, Novel Immunotherapies, & Vascular Risk - What Does the Practitioner Need to Know?

Speaker(s)

• 

  Nicolas Palaskas, MD MPH

  Associate Professor
  UT MD Anderson Cancer Center